United Kingdom · Report · Written statement
UIN HCWS797
Revised advice on the safety of UK plasma for fractionation to make immunoglobulins
Introduced
25 February 2021
Last action
25 February 2021 · Written statement
Status
Commons
Sponsors
—
Subjects
Discovery layer
Source updated
25 February 2021
Summary
I would like to inform the House that the Government has decided to allow the use of UK sourced plasma for the manufacture of immunoglobulins.In the wake of the Bovine Spongiform Encephalopathy (BSE) epidemic in the 1990s, a number of extra precautionary ...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 February 2021
Written statement
I would like to inform the House that the Government has decided to allow the use of UK sourced plasma for the manufacture of immunoglobulins.In the wake of the Bovine Spongiform Encephalopathy (BSE) epidemic in the 1990s, a number of extra precautionary ...
Source: Commons
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2021-02-25/HCWS797
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/1289735
- uk · ws-1289735 · source updated 25 February 2021